You are here

Eli Lilly

Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch.

BioPharma Dive

Fri, 10/11/24 - 11:10 am

Skye Bioscience

Lilly names Mount Sinai scientist as first chief AI officer

BioPharma Dive

Wed, 10/9/24 - 09:05 pm

artificial intelligence

Lilly, Insitro Ink Unique AI Deal, Eye Novel Treatments for Metabolic Diseases

BioSpace

Wed, 10/9/24 - 09:46 am

Weight loss gold rush: Developers vie for next blockbuster treatment

Pharmaphorum

Tue, 10/8/24 - 09:45 am

Boehringer Ingelheim

Lilly's weight-loss drug removed from FDA's shortage list

Reuters

Thu, 10/3/24 - 10:06 am

High-flying Eli Lilly pushes more chips forward with $4.5B 'Medicine Foundry' project

Fierce Pharma

Wed, 10/2/24 - 11:27 am

medicine foundry

drug manufacturing

Weight Loss From GLP-1 Drugs Not As Robust In Real-World Settings

Forbes

Wed, 10/2/24 - 11:20 am

Patients sue over alleged stomach paralysis linked to Ozempic, Mounjaro

Beckers Hospital Review

Tue, 10/1/24 - 10:45 am

Radiopharma biotech Aktis sees Big Pharma backers return for $175M series B

Fierce Biotech

Mon, 09/30/24 - 09:40 am

radiopharmaceuticals

Inside the GLP-1 'price war'

Beckers Hospital Review

Tue, 09/24/24 - 11:52 am

Eli Lilly's Alzheimer's drug approved in Japan

Reuters

Tue, 09/24/24 - 11:39 am

Alzheimer's disease

New migraine drugs less effective than previous generation of triptan meds: BMJ study

Fierce Pharma

Thu, 09/19/24 - 09:29 pm

Novartis heaps pressure on Lilly with broad FDA approval for Kisqali in early breast cancer

Fierce Pharma

Tue, 09/17/24 - 11:08 pm

ESMO 2024: Eli Lilly brings the competition to Novartis with new results in mCRPC

Clinical Trials Arena

Tue, 09/17/24 - 11:13 am

lutetium zadavotide guraxetan

metastatic castration-resistant prostate cancer

FDA approves Eli Lilly's drug for eczema

Reuters

Mon, 09/16/24 - 10:16 pm

How Lilly’s sustainability goals come face to face with massive growth

Pharma Voice

Thu, 09/12/24 - 10:17 am

drug manufacturing

Lilly delivers one-two punch with 2nd tranche of positive data on weekly insulin candidate

Fierce Biotech

Wed, 09/11/24 - 11:07 pm

Weight-loss market to see 16 new drugs by 2029, report estimates

Reuters

Tue, 09/10/24 - 04:29 pm

Boehinger Ingelheim

Structure Therapeutics

Viking Therapeutics

Lilly-backed Superluminal raises $120M series A to bring membrane receptor drugs into the clinic

Fierce Biotech

Mon, 09/9/24 - 10:46 am

Superluminal Medicines

small molecule drugs

57 Million Eligible For GLP-1 Drug Coverage In U.S. And That’s Just Those Under 65

Forbes

Thu, 09/5/24 - 10:29 pm

Pages